These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38649226)

  • 21. The effect of indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.
    Ahmad D; Lopez KT; Esmadi MA; Oroszi G; Matteson-Kome ML; Choudhary A; Bechtold ML
    Pancreas; 2014 Apr; 43(3):338-42. PubMed ID: 24622061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials.
    Patai Á; Solymosi N; Mohácsi L; Patai ÁV
    Gastrointest Endosc; 2017 Jun; 85(6):1144-1156.e1. PubMed ID: 28167118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk Factors for Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis and the Effect of Octreotide Combined with Nonsteroidal Anti-Inflammatory Drugs on Preventing Its Occurrence.
    Wang J; Shen Y; Zhong Z; Wu S; Zheng L
    Med Sci Monit; 2018 Dec; 24():8964-8969. PubMed ID: 30531679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of rectal indomethacin on the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography for choledocholithiasis: a prospective randomized clinical trial.
    Liu KJ; Hu Y; Guo SB
    Rev Esp Enferm Dig; 2024 Apr; 116(4):20-208. PubMed ID: 37982566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tacrolimus and Indomethacin Are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation.
    Thiruvengadam NR; Forde KA; Chandrasekhara V; Ahmad NA; Ginsberg GG; Khungar V; Kochman ML
    Clin Gastroenterol Hepatol; 2020 May; 18(5):1224-1232.e1. PubMed ID: 31622734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial.
    Elmunzer BJ; Foster LD; Serrano J; Coté GA; Edmundowicz SA; Wani S; Shah R; Bang JY; Varadarajulu S; Singh VK; Khashab M; Kwon RS; Scheiman JM; Willingham FF; Keilin SA; Papachristou GI; Chak A; Slivka A; Mullady D; Kushnir V; Buxbaum J; Keswani R; Gardner TB; Forbes N; Rastogi A; Ross A; Law J; Yachimski P; Chen YI; Barkun A; Smith ZL; Petersen B; Wang AY; Saltzman JR; Spitzer RL; Ordiah C; Spino C; Durkalski-Mauldin V;
    Lancet; 2024 Feb; 403(10425):450-458. PubMed ID: 38219767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients.
    Levenick JM; Gordon SR; Fadden LL; Levy LC; Rockacy MJ; Hyder SM; Lacy BE; Bensen SP; Parr DD; Gardner TB
    Gastroenterology; 2016 Apr; 150(4):911-7; quiz e19. PubMed ID: 26775631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis.
    Feng Y; Navaneethan U; Zhu X; Varadarajulu S; Schwartz I; Hawes R; Hasan M; Yang A
    Dig Endosc; 2017 May; 29(3):272-280. PubMed ID: 27914176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does melatonin addition to indomethacin decrease post endoscopic retrograde cholangiopancreatography pancreatitis? A randomized double-blind controlled trial.
    Sadeghi A; Abbasinazari M; Asadzadeh Aghdaei H; Abdi S; Hatami B; Rasoolinezhad M; Jamshidzadeh S; Saadati S
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1350-1355. PubMed ID: 31524774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Adding Intravenous Somatostatin to Rectal Indomethacin on Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis in High-risk Patients: A Double-blind Randomized Placebo-controlled Clinical Trial.
    Norouzi A; Ghasem Poori E; Kaabe S; Norouzi Z; Sohrabi A; Amlashi FI; Tavasoli S; Besharat S; Ezabadi Z; Amiriani T
    J Clin Gastroenterol; 2023 Feb; 57(2):204-210. PubMed ID: 34049378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NSAIDs for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: ready for prime time?
    Parsi MA
    World J Gastroenterol; 2012 Aug; 18(30):3936-7. PubMed ID: 22912542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
    Mohammad Alizadeh AH; Abbasinazari M; Hatami B; Abdi S; Ahmadpour F; Dabir S; Nematollahi A; Fatehi S; Pourhoseingholi MA
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):349-354. PubMed ID: 27849643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rectal indomethacin with topical epinephrine versus indomethacin alone for preventing Post-ERCP pancreatitis - A systematic review and meta-analysis.
    Aziz M; Ghanim M; Sheikh T; Sharma S; Ghazaleh S; Fatima R; Khan Z; Lee-Smith W; Nawras A
    Pancreatology; 2020 Apr; 20(3):356-361. PubMed ID: 32107191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Sethi S; Sethi N; Wadhwa V; Garud S; Brown A
    Pancreas; 2014 Mar; 43(2):190-7. PubMed ID: 24518496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis: rectal indomethacin for the prevention of post-ERCP pancreatitis.
    Yaghoobi M; Rolland S; Waschke KA; McNabb-Baltar J; Martel M; Bijarchi R; Szego P; Barkun AN
    Aliment Pharmacol Ther; 2013 Nov; 38(9):995-1001. PubMed ID: 24099466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is combining therapy with indomethacin and epinephrine useful for preventing post-ERCP pancreatitis? The answer from a meta-analysis.
    Laoveeravat P; Perisetti A; Garcia-Saenz-de-Sicilia M; Garg S; Tharian B
    Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):459-460. PubMed ID: 32011390
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of stent and indomethacin suppository efficacy in the prevention of acute pancreatitis after ERCP.
    Icacan G; Onalan E; Yucesoy M
    Acta Biomed; 2021 Sep; 92(4):e2021178. PubMed ID: 34487093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement.
    Choksi NS; Fogel EL; Cote GA; Romagnuolo J; Elta GH; Scheiman JM; Chak A; Mosler P; Higgins PD; Korsnes SJ; Schmidt SE; Sherman S; Lehman GA; Elmunzer BJ;
    Gastrointest Endosc; 2015 Jan; 81(1):150-5. PubMed ID: 25527053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Cost-Effectiveness Analysis for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Prophylaxis in the United States.
    Thiruvengadam NR; Saumoy M; Schneider Y; Attala S; Triggs J; Lee P; Kochman ML
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):216-226.e42. PubMed ID: 34481952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography.
    Thiruvengadam NR; Forde KA; Ma GK; Ahmad N; Chandrasekhara V; Ginsberg GG; Ho IK; Jaffe D; Panganamamula KV; Kochman ML
    Gastroenterology; 2016 Aug; 151(2):288-297.e4. PubMed ID: 27215656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.